Is TerrAscend, With a Promising Track Record, Projected to Take the Lead in the Cannabis Industry?

Photo of author
Written By Joel Gbolade

TerrAscend (OTCQX:TSNDF) has garnered attention in the investment community, with its performance and potential being subject to various analyses. Despite recent fluctuations in its stock price, TerrAscend remains a focal point due to its unique position in the cannabis industry. The stock is currently trading at $1.61 and is up only 5% since May 12, 2023.

By the end of the year it reached $1.63, with just 1% growth.

Read More: Investing in The Stock Market vs Real Estate: Why The Stock Market is Better for the Majority of People

History and Transition

TerrAscend | Leading Vertically-Integrated Cannabis Operator
Credits: TerrAscend

Originally listed on the Canadian Securities Exchange in 2017 as a Canadian LP, TerrAscend has undergone significant evolution. Transitioning to the Toronto Stock Exchange and exiting Canada in 2023, the company has become exclusively focused on the MSO market. This strategic shift has been perceived as both distinctive and impactful within the industry.

Strategic Partnerships

One pivotal moment in TerrAscend’s journey was its early investment by Canopy Growth (CGC) in 2017. This partnership has evolved over time, with Canopy Growth now holding a substantial stake in TerrAscend. Additionally, TerrAscend’s strategic acquisitions, such as the Apothecarium in California and Gage Growth in Michigan, have bolstered its presence in key U.S. markets.

Expansion and Operations

TerrAscend’s expansion into various states, with a number of outlets in Pennsylvania, Maryland, and New Jersey, has broadened its footprint in the U.S. cannabis market. With operations spanning multiple states and a diversified portfolio of products, TerrAscend is poised for further growth. As, the company operates 33 dispensaries across 6 states.


A notable change in TerrAscend’s leadership occurred with the appointment of Ziad Ghanem as CEO in 2023. Ghanem’s extensive experience in the healthcare industry, including his tenure at Walgreen’s Boots Alliance, brings valuable expertise to the company’s executive team.

Financial Performance

Despite challenges in 2022, TerrAscend demonstrated robust financial performance in 2023. According to analysts, the company reported a total revenue growth of 29%, reaching $320 million in total revenue for the fiscal year. Adjusted EBITDA also showed significant improvement, reaching $72 million for the same period.

Also Read: Energy Secretary Expresses US’s Deep Concerns Over China’s Control in Critical Minerals Market

Valuation and Outlook

Analysts project continued growth for TerrAscend in the coming years. According to Sentieo, the company is expected to achieve an 18% revenue growth and a 29% growth in adjusted EBITDA for 2024. While concerns persist regarding debt levels and tangible equity, TerrAscend’s valuation appears reasonable compared to peers.

Promising Future and Growth

TerrAscend’s performance relative to MSO peers has been mixed, with recent underperformance offsetting earlier successes. However, its strategic positioning in key markets and potential for growth make it an intriguing investment opportunity.

TerrAscend | Leading Vertically-Integrated Cannabis Operator
Credits: TerrAscend

Investors should carefully consider the risks and rewards associated with owning TerrAscend, particularly amidst uncertainties surrounding regulatory changes and market dynamics.

Read Next: This Stock is up Almost 80% in The Past Year: Will the Trend Continue?


You should read and understand this disclaimer in its entirety before joining or viewing the website or email/blog list of (the “Publisher”). The information (collectively the “Advertisement”) disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, and/or losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply. To unsubscribe from receiving promotional text messages to your phone sent via an autodialer, using your phone reply to the sender’s phone number with the word STOP or HELP for help.

The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission (the "SEC") at; the Financial Industry Regulatory Authority (the "FINRA") at, and relevant State Securities Administrator website and the OTC Markets website at The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete.

The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial and/or legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete.

By your subscription to our profiles, the viewing of this profile and/or use of our website, you have agreed and acknowledged the terms of our full disclaimer and privacy policy which can be viewed at the following link: and

By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of (1) a client company, (2) the party issuing or preparing the information for the company, or (3) other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated report/release or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink.